A leading global provider of laboratory testing services for clinical trials was interested in assessing the possibility of implementing a new phase IV clinical trials business model. They relied on Kineticos to provide insight into its commercial viability and examine the business case. The laboratory’s primary objective was to evaluate the business case to determine if they should move forward.


Kineticos performed a comprehensive risks/benefits evaluation including an examination of 10 competitor models. We evaluated the company’s current procedures and processes and developed an alternative business model and business case.


Kineticos provided a thorough business case report demonstrating the business model would increase convenience and reduce costs for phase IV clinical trial patients. Overall, the new procedures and services using the provider’s existing resources and capabilities for phase IV clinical trials laboratories were shown to be more efficient and a cost-saving process.